One of the listed companies, Ambee Pharmaceuticals Limited, discloses its financial reports for the third quarter, (January – March 23). This source is known from DSE.
The company’s earnings per share (EPS) of Tk 0.70 paisa in Q3 of the current financial year. EPS was Tk 0.40 paisa during the same period last year.
As of March 31, 2023, the net asset value (NAVPS) was Tk 19.02 paisa.
Share this
